Trademark: 87516334
Word
CHALLENGE ACCEPTED
Status
Registered
Status Code
700
Status Date
Tuesday, February 6, 2018
Serial Number
87516334
Registration Number
5395382
Registration Date
Tuesday, February 6, 2018
Mark Type
4000
Filing Date
Wednesday, July 5, 2017
Published for Opposition
Tuesday, November 21, 2017

Trademark Owner History
Avista Pharma Solutions, Inc. - Original Registrant

Classifications
40 Early to late phase drug manufacturing services for others; and manufacturing of drug substances and custom synthesis for new or transferred substances for others
42 Scientific, technological and testing services, namely, microbiological testing in the pharmaceutical and medical device industries; container closure integrity testing; bacterial filter integrity testing; mycoplasma testing; sterilization validation testing; cleaning validation testing; package validation testing; accelerated aging studies, namely, conducting technical research in the field of product aging; disinfectant qualification programs for clean rooms, namely, developing quality control standards for clean rooms; clean room testing and support services in the nature of monitoring clean room manufacturing practices for quality control operational and design purposes; clean room environmental monitoring services, namely, air surface monitoring, personnel monitoring in the nature of conducting surveys to determine if clean room employees meet employee clean room requirements and standards, temperature and humidity monitoring, pressure differential monitoring, incubation analysis and reporting and isolate characterization and identification; product research and process chemistry services in the pharmaceutical industry; analytical testing and development services for the pharmaceutical industry, namely, structural determination and impurity identification; material characterization, namely, materials testing; evaluation of potential genotoxic impurities in the production of drugs; impurity isolation, namely, chemical laboratory services in the field of impurity isolation for the pharmaceutical industry; analysis of raw materials to specifications; analytical testing to monitor the synthesis and release of drugs; bioanalytical analysis to support discovery and preclinical drug metabolism studies; conducting stability studies of pharmaceutical products; and research and development of drug formulations

Trademark Events
Feb 6, 2023
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Dec 16, 2020
Assignment Of Ownership Not Updated Automatically
Feb 10, 2020
Teas Change Of Correspondence Received
Dec 11, 2019
Assignment Of Ownership Not Updated Automatically
Feb 6, 2018
Registered-Principal Register
Nov 21, 2017
Official Gazette Publication Confirmation E-Mailed
Nov 21, 2017
Published For Opposition
Nov 1, 2017
Notification Of Notice Of Publication E-Mailed
Oct 15, 2017
Approved For Pub - Principal Register
Sep 29, 2017
Assigned To Examiner
Jul 12, 2017
New Application Office Supplied Data Entered
Jul 8, 2017
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24